ESC 365 - The science of HDL and reverse cholesterol transport – Are we still hopeful?

Open Access

The science of HDL and reverse cholesterol transport – Are we still hopeful?

Session: Cardiovascular risk reduction and lipid management: state of the science

Topic: Metabolism and metabolic syndromes

Speaker: Professor J. Kastelein (Amsterdam, NL)

Sponsored by Cleveland Clinic

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor John Kastelein

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))

34 presentations

6 followers

3 more presentations in this session

Unmet medical needs with current agents and residual CV risk: rationale for developing new agents.

Speaker: Professor S. Nissen (Cleveland, US)

New horizons for the statin intolerant patients: current and future therapeutic options.

Speaker: Doctor L. Cho (Cleveland, US)

Prospects for clinical benefit with CETP inhibition in light of current and future trials.

Speaker: Professor A. Lincoff (Cleveland, US)

Access the full session

Cardiovascular risk reduction and lipid management: state of the science

Speakers: Professor J. Kastelein, Professor S. Nissen, Doctor L. Cho, Professor A. Lincoff

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources